Illumina | ILMN - Selling And Administration Expenses


Illumina reported $273M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Agilent USD 475M 10M Jun/2026
Bio Techne USD 109.34M 4.35M Mar/2026
Bio-Rad Laboratories USD 212M 400K Jun/2026
Boston Scientific USD 1.68B 120M Sep/2026
Bruker USD 238.9M 3.2M Jun/2026
Charles River Laboratories USD 228.9M 69.47M Jun/2026
Danaher USD 2.16B 87M Sep/2026
Dentsply International USD 364M 13M Jun/2026
Edwards Lifesciences USD 561.2M 39M Jun/2026
Illumina USD 273M 1000K Jun/2026
Intuitive Surgical USD 1.08B 465.5M Sep/2026
IQVIA Holdings USD 569M 5M Sep/2026
Laboratory Of America USD 611.4M 34.2M Sep/2026
Mettler Toledo International USD 263.33M 5.01M Jun/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Quest Diagnostics USD 523M 6M Sep/2026
Quidel USD 189.7M 9.6M Jun/2026
Repligen USD 83.59M 6.97M Sep/2026
Revvity USD 278.58M 24.69M Jun/2026
Roche Holding CHF 6.37B 908M Jun/2026
Standard Biotools USD 18.61M 2.94M Mar/2026
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
Waters USD 405M 11M Jun/2026